Clinical Trials

1 results for Kidney/Renal Cancer


Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma

  • Condition: Renal Cell Carcinoma
  • Study ID: NCT06053658
View Trial